Clinical Trial Update: Perioperative Immunotherapy vs. Chemo-immunotherapy in Patients With Advanced GC and AEG [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing perioperative immunotherapy to chemo-immunotherapy in advanced gastric cancer and esophagogastric junction adenocarcinoma; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Esophagogastric Junction
• Gastric Cancer

Snippet

Sponsor: University Hospital, Essen | Conditions: Gastric Cancer, Adenocarcinoma of the Esophagogastric Junction | Phase 2 | Status: UNKNOWN